FDA accepts Genentech’s IND for neoantigen-directed T-cell therapy product for solid tumors
Genentech Inc., a member of the Roche Group, has received IND clearance by the FDA for a… Read More
Pharma
Salipro and Dynabind identify small-molecule compounds that bind to challenging membrane protein target
Salipro Biotech AB and Dynabind GmbH have achieved a key milestone under their… Read More
Roche patents monoglyceride lipase inhibitors
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have patented heterocyclic compounds… Read More
Snipr Biome engineers CRISPR-Cas-armed phages targeting E. coli
The increasing emergence of antibiotic-resistant pathogens makes the finding of new options to… Read More
Amgen deal in Crohn’s sends Tscan stock soaring; $530M potential
A preview of the next edition of BioWorld, May 9, 2023 Read More
4dmedical raises AU$20M to accelerate commercialization of lung ventilation software
With AU$20 million (US$13.56 million) in new funding, 4dmedical Ltd. is ramping up its commercialization efforts of its four-dimensional lung imaging platform in the U.S. Read More
UK, Australia responding to EU delays for regulatory deadlines
The recent decision by the EU to delay the implementation dates for the Medical Device Regulation (MDR) initiative is having ripple effects across the globe as other regulatory jurisdictions Read More
Financings for May 9, 2023
Med-tech firms raising money in public or private financings, including: Ascertain, Lucem Health, Optain, Sensydia, Transmedics. Read More